Neurology

The FDA approved a treatment that targets one of the main causes of Alzheimer disease.

Researchers updated the 2014 INCOG Guidelines that outline how clinicians should approach cognitive rehabilitation for individuals who have traumatic brain injury.

This COVID-19 roundup includes coverage of the FDA’s modification of bivalent vaccines in infants aged 6 months, the NIH advises against the use of bebtelovimab, and impact COVID-19 has on short-term...

In the largest study to date, researchers examined a possible link between anesthesia in pregnant women and neurodevelopmental outcomes in their children.

The study findings suggest that an increased amount of steps each day may lessen the chance of developing dementia later in life

The US Food and Drug Administration has cleared a new method for computed tomography (CT) imaging, in addition to a recently cleared new biomedical imaging technology.

A joint guideline was recently issued on the prevention, management, and treatment of individuals with spontaneous intracerebral hemorrhage.

The FDA has approved a new form of treatment for adults with amyotrophic lateral sclerosis, commonly known as Lou Gehrig disease.

In this COVID-19 roundup, we discuss the recent limitation for the use of the Janssen COVID-19 vaccine, the seroprevalence of asymptomatic infection, neurologic symptoms associated with COVID-19, and...